Manufacturing

New Agitation Stress Model Boosts Biologics Stability Testing
Biotech & Bioprocessing New Agitation Stress Model Boosts Biologics Stability Testing

I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development. With a sharp focus on technology and innovation, Ivan has been at the forefront of advancing biologics formulation, particularly in tackling the complex challenges of

FDA Speeds Biosimilar Approvals to Slash Drug Costs
Research & Development FDA Speeds Biosimilar Approvals to Slash Drug Costs

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a keen understanding of technology and innovation, makes him a leading voice in the industry. Today, we’re diving into the FDA’s recent push to accelerate

What Makes Taiwan a Biotech Leader at BioJapan 2025?
Management & Regulatory What Makes Taiwan a Biotech Leader at BioJapan 2025?

Taiwan is carving out a formidable reputation in the global biotech arena, and its participation in BioJapan 2025, taking place from October 8-10 at PACIFICO Yokohama in Yokohama, Japan, is a testament to this ascent. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO),

Elos Medtech Redefines Medical Device Innovation and Collaboration
Management & Regulatory Elos Medtech Redefines Medical Device Innovation and Collaboration

In an era where medical technology is advancing at an unprecedented pace, Elos Medtech, a Sweden-based global leader in the medical device industry, stands out as a transformative force driving progress and partnership. Operating as both a contract development and manufacturing organization (CDMO)

Automation Reshapes Medical Device Manufacturing by 2035
Management & Regulatory Automation Reshapes Medical Device Manufacturing by 2035

The medical device manufacturing sector is undergoing a seismic shift, with automation emerging as the cornerstone of innovation and efficiency as the industry looks toward 2035, driven by the urgent need to meet rising global healthcare demands. Projections from recent market analyses indicate

How Will Three Key Strategies Shape Cell and Gene Therapy?
Biotech & Bioprocessing How Will Three Key Strategies Shape Cell and Gene Therapy?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later